Who is sponsoring NCT04285047?

NCT04285047 is sponsored by Optimum Patient Care.

What drugs are being tested in NCT04285047?

Interventions in NCT04285047: Advancing Patient Experience (APEX) in COPD.

What condition does NCT04285047 study?

NCT04285047 studies Chronic Obstructive Pulmonary Disease (13645005).

Is NCT04285047 still recruiting?

NCT04285047 is currently status unknown. Last updated 26 February 2020.

Last reviewed 2020-02-26 · How we verify

NCT04285047: APEX COPD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Advancing the Patient Experience in Chronic Obstructive Pulmonary Disease (APEX COPD)

Status unknown Last updated 26 February 2020

What this trial tests

trial testing Advancing Patient Experience (APEX) in COPD in Chronic Obstructive Pulmonary Disease (13645005) in 4,500 participants. Status unknown.

Timeline

23 March 2019

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Optimum Patient Care
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	4,500
Start date	23 March 2019
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	4 locations across United States

Drugs / interventions tested

Advancing Patient Experience (APEX) in COPD

Conditions studied

Chronic Obstructive Pulmonary Disease (13645005) — all drugs for Chronic Obstructive Pulmonary Disease (13645005) →

Sponsor

Optimum Patient Care

Who can join

35 and older, any sex, with Chronic Obstructive Pulmonary Disease (13645005). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

APEX COPD is registry to provide a mechanism to standardize, store and utilize data to enable greater power to answer key research questions, and to improve patient outcomes in COPD primary care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04285047 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Optimum Patient Care
Last refreshed: 26 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04285047.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing